Ernest Borden, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
Duke University School of Medicine
Medical School
Duke University Hospital
Internship
University of Pennsylvania Health System
Residency
Johns Hopkins University
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
OH State Medical License Active through 2015
NC State Medical License Active through 2017
CLEVELAND CLINIC HOSPITAL
Languages: English/Spanish
(216) 445-0150
9500 Euclid Ave Taussig Cancer Institute
Read MoreAdjuvant Chemotherapy for Stage II Rectal Cancer.
Deming D, Uboha N, Zafar SY, Rosenberg S, Bassetti M, Glasgow S, Borden EC, Lubner S; Semin. Oncol.. 2015-12-01
See more >>Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
Joshi P, Jacobs B, Derakhshan A, Moore LR, Elson P, Triozzi PL, Borden E, Zborowski M; Oncotarget. 2014-05-15.
See more >>The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon.
Triozzi PL, Achberger S, Aldrich W, Singh AD, Grane R, Borden EC; J Transl Med. 2012-12-05.
See more >>